China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

[Coupang Inc. (CPNG US) Earnings Preview]: Market Share Solid Given Limited Competitive Threat

[Coupang Inc. (CPNG US) Target Price Change]: Fulfilment of 3P Orders Is Next Revenue Driver

Coupang(CPNG US, SELL, TP US$15.1) Rating Change: Facing More Competition from AliExpress,DG to Sell

Coupang(CPNG US) Rating Change: Margin Still Has Upside, Upgrade to BUY

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

China/Asia TMT

Shawn Yang

Equity Bottom-Up

<ul>
<li>Coupang reported C4Q22 total revenue missed our est. and cons. by (5%) and (2%). Net income missed our est. by (9%) and beat cons. by 18%. </li>
<li>We see upsides in margin due to change in product mix, higher contribution in ads, and optimization in logistics.</li>
<li>We trimmed our 2023 total revenue growth est. by (4%) and raise net income est. by 9% for operating efficiency improvement. Maintain BUY.</li>
</ul>


Coupang reported C4Q22 total revenue missed our est. and cons. by (5%) and (2%). Net income missed our est. by (9%) and beat cons. by 18%. 
We see upsides in margin due to change in product mix, higher contribution in ads, and optimization in logistics.
We trimmed our 2023 total revenue growth est. by (4%) and raise net income est. by 9% for operating efficiency improvement. Maintain BUY.


[Coupang Inc. (CPNG US) Earnings Review]: Upsides Ahead in Category and Margin Expansion